Could a simple zinc pill help control a rare brain disorder?
NCT ID NCT06412653
Summary
This small pilot study tested whether taking a daily zinc supplement for six months is safe and practical for people with GNAO1 disorders, a rare genetic condition that causes movement problems, seizures, and developmental delays. Researchers enrolled 13 participants, aged 6 months to 30 years, to see if the treatment was manageable and to check for any side effects. They also looked for potential changes in symptoms like involuntary movements, seizure frequency, sleep, behavior, and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Children's Hospital, University Hospital Cologne, University of Cologne
Cologne, 50937, Germany
Conditions
Explore the condition pages connected to this study.